Cancer Moonshot: Hurone AI featured in White House release 

Hurone AI’s work in addressing the cancer care gap in Africa was featured in the recent White House Cancer Moonshot release. The release highlights our partnership with the Amazon Web Services (AWS) Health Equity Initiative towards advancing health equity in Africa.

According to the White House fact sheet:

“Amazon Web Services (AWS) as part of its global $40 million Health Equity Initiative will bridge the gaps in cancer care outcomes in underserved regions. Through this program, AWS has supported Seattle-based startup Hurone AI, which is democratizing access to high-quality cancer prevention and care by building artificial intelligence-powered applications derived from data sources and algorithms from people of African descent.”

The press statement also shone a spotlight on Hurone AI’s Gukiza application, which enables oncologists to provide remote patient monitoring. The Gukiza app is currently being test-run in Rwanda with plans to scale to other countries in Sub-Saharan Africa and beyond in the nearest future.

“I am ecstatic about this endorsement and I’m so grateful for everyone who has worked hard to get Hurone AI to this point. This feature is pivotal for us as a company, and it’s also a humbling reminder of how important our vision is,” Hurone AI Founder and Chief Strategist, Kingsley Ndoh said in response to the release.

“Making cancer care accessible to people in Africa and all over the world is a necessary step in the right direction and I look forward to the great impact that Hurone AI will have alongside AWS and other organizations that are committed to reducing the world’s cancer burden and making high quality healthcare accessible to everyone,” he concluded.

The latest Cancer Moonshot update was published as part of the 2022 U.S.- Africa Leaders Summit to announce new actions from U.S. departments and agencies and the private sector to reduce the cancer burden in Africa and improve cancer outcomes.

Floria Nyandaya

R & D Strategy Fellow, Hurone AI

Floria Nyandaya is a physician-scientist dedicated to tackling health disparities in non-communicable diseases(NCDs) amidst Africa’s epidemiological transition. 

With a diverse background in primary clinical practice, healthcare management, infectious disease surveillance and NCD research, she has recently expanded her focus to digital health technologies. As a recipient of the Cardiometabolic Research Fellowship and the Thomas Francis Jr. Global Health Fellowship in her MPH program, Floria gained hands-on global health experience in the U.S., Nigeria, and Kenya. 

Her research endeavors have been multifaceted, from advancing women’s cardiovascular health to exploring the utility of artificial intelligence in enhancing renal and cancer care and addressing diversity gaps in clinical trial research. Continuously driven by her passion for making a tangible difference, Floria remains dedicated to improving the health and well-being of underserved populations.

 
Lisette Martje Rauwendaal

Head of Communications

Head of Communications at Hurone AI, where she leads brand strategy, corporate communications, and strategic storytelling. With over 15 years of experience building social impact and CSR programs for global technology companies, Lisette specializes in aligning business strategy with meaningful community engagement.

Previously, Lisette held senior leadership roles at Amazon and Malwarebytes. At Amazon, she led global supplier education and social impact communications, scaling AI-enabled workflows, increasing supplier engagement by 200% year-over-year, and driving measurable ROI across complex international stakeholder environments. At Malwarebytes, she launched the company’s first corporate social impact program, secured national media coverage including NBC, and increased press reach by over 50% year-over-year.

Lisette brings deep expertise in stakeholder management, media strategy, AI-enabled operations, and purpose-driven brand building, helping technology companies translate mission into measurable impact.